Association between Accessory Gene Regulator Polymorphism and Mortality among Critically Ill Patients Receiving Vancomycin for Nosocomial MRSA Bacteremia: A Cohort Study
Background. Polymorphism of the accessory gene regulator group II (agr) in methicillin-resistant Staphylococcus aureus (MRSA) is predictive of vancomycin failure therapy. Nevertheless, the impact of group II agr expression on mortality of patients with severe MRSA infections is not well established...
Main Authors: | Cechinel, Angélica, Machado, Denise P., Turra, Eduardo, Pereira, Dariane, dos Santos, Rodrigo P., Rosa, Regis G., Goldani, Luciano Z. |
---|---|
Format: | Online |
Language: | English |
Published: |
Hindawi Publishing Corporation
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904565/ |
Similar Items
-
Vancomycin-Resistant Enterococcus faecium Bacteremia in a Tertiary Care Hospital: Epidemiology, Antimicrobial Susceptibility, and Outcome
by: Rosa, Regis G., et al.
Published: (2014) -
Vancomycin resistance among MRSA
by: Kumar, V. Anil
Published: (2012) -
Nosocomial methicillin-resistant staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy
by: Pletz, Mathias W, et al.
Published: (2010) -
Difference in agr Dysfunction and Reduced Vancomycin Susceptibility between MRSA Bacteremia Involving SCCmec Types IV/IVa and I–III
by: Jang, Hee-Chang, et al.
Published: (2012) -
The effect of improved hand hygiene on nosocomial MRSA control
by: Marimuthu, Kalisvar, et al.
Published: (2014)